Cargando…

Use of Levosimendan in Patients with Advanced Heart Failure: An Update

Levosimendan is an inodilator drug that, given its unique pharmacological actions and safety profile, represents a viable therapeutic option in patients with heart failure with reduced ejection fraction in the advanced stage of the disease (advHFrEF). Pulsed levosimendan infusion in patients with ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masarone, Daniele, Kittleson, Michelle M., Pollesello, Piero, Marini, Marco, Iacoviello, Massimo, Oliva, Fabrizio, Caiazzo, Angelo, Petraio, Andrea, Pacileo, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659135/ https://www.ncbi.nlm.nih.gov/pubmed/36362634 http://dx.doi.org/10.3390/jcm11216408

Ejemplares similares

Levosimendan as a “Bridge to Optimization” in Patients with Advanced Heart Failure with Reduced Ejection—A Single-Center Study
por: Masarone, Daniele, et al.
Publicado: (2022)

The Role of Echocardiography in the Management of Heart Transplant Recipients
por: Masarone, Daniele, et al.
Publicado: (2021)

The ABC of Heart Transplantation—Part 1: Indication, Eligibility, Donor Selection, and Surgical Technique
por: Masarone, Daniele, et al.
Publicado: (2023)

Left Ventricular Assist Device Implantation in a Thrombosed Apical Aneurysm
por: Masarone, Daniele, et al.
Publicado: (2021)

Use of Cardiac Contractility Modulation as Bridge to Transplant in an Obese Patient With Advanced Heart Failure: A Case Report
por: Masarone, Daniele, et al.
Publicado: (2022)

Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018)

Risk Stratification of Sudden Cardiac Death in Patients with Heart Failure: An update
por: Masarone, Daniele, et al.
Publicado: (2018)

Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application
por: Bouchez, S., et al.
Publicado: (2018)

Rehospitalization after intermittent levosimendan treatment in advanced heart failure patients: a meta‐analysis of randomized trials
por: Silvetti, Simona, et al.
Publicado: (2017)

The inodilator levosimendan in repetitive doses in the treatment of advanced heart failure
por: Delgado, Juan F., et al.
Publicado: (2017)

Repetitive levosimendan treatment in the management of advanced heart failure
por: Oliva, Fabrizio, et al.
Publicado: (2018)

Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan
por: Agostoni, Piergiuseppe, et al.
Publicado: (2019)

The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2021)

Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications
por: Altenberger, Johann, et al.
Publicado: (2018)

Berlin Heart EXCOR® pediatric ventricular assist device in a patient with Sotos syndrome: a case report
por: Gravino, Rita, et al.
Publicado: (2019)

Effects of Cardiac Contractility Modulation Electrodes on Tricuspid Regurgitation in Patients with Heart Failure with Reduced Ejection Fraction: A Pilot Study
por: Masarone, Daniele, et al.
Publicado: (2022)

Pathophysiology-Based Management of Acute Heart Failure
por: Falco, Luigi, et al.
Publicado: (2023)

Levosimendan‐induced venodilation is mediated by opening of potassium channels
por: Burkhoff, Daniel, et al.
Publicado: (2021)

The Effects of Device-Based Cardiac Contractility Modulation Therapy on Left Ventricle Global Longitudinal Strain and Myocardial Mechano-Energetic Efficiency in Patients with Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2022)

Levosimendan in Europe and China: An Appraisal of Evidence and Context
por: Kong, Xiangqing, et al.
Publicado: (2021)

Management of Arrhythmias in Heart Failure
por: Masarone, Daniele, et al.
Publicado: (2017)

Levosimendan Improves Oxidative Balance in Cardiogenic Shock/Low Cardiac Output Patients
por: Grossini, Elena, et al.
Publicado: (2020)

Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice
por: Guarracino, Fabio, et al.
Publicado: (2018)

Facing up to the challenges of acute heart failure
por: Pollesello, Piero
Publicado: (2020)

Levosimendan improves exercise performance in patients with advanced chronic heart failure
por: Mushtaq, Saima, et al.
Publicado: (2015)

Vericiguat: The Fifth Harmony of Heart Failure with Reduced Ejection Fraction
por: Falco, Luigi, et al.
Publicado: (2023)

Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper
por: Herpain, Antoine, et al.
Publicado: (2019)

Haemodynamic effects of levosimendan in advanced but stable chronic heart failure
por: Najjar, Emil, et al.
Publicado: (2018)

A review of levosimendan in the treatment of heart failure
por: Kasikcioglu, Hulya Akhan, et al.
Publicado: (2006)

Levosimendan in pulmonary hypertension and right heart failure
por: Hansen, Mona Sahlholdt, et al.
Publicado: (2018)

Effects of Sacubitril/Valsartan on the Right Ventricular Arterial Coupling in Patients with Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2020)

Beta Blockers Up-Titration in Patients with Heart Failure Reduced Ejection Fraction and Cardiac Resynchronization Therapy, a Single Center Study
por: Masarone, Daniele, et al.
Publicado: (2019)

The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure
por: Nieminen, Markku S., et al.
Publicado: (2017)

Levosimendan in acute and advanced heart failure: still some chapters to be written
por: Pölzl, Gerhard
Publicado: (2018)

Newer treatments for decompensated heart failure: focus on levosimendan
por: Follath, Ferenc
Publicado: (2009)

Levosimendan Inhibits Peroxidation in Hepatocytes by Modulating Apoptosis/Autophagy Interplay
por: Grossini, Elena, et al.
Publicado: (2015)

The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
por: Levijoki, Jouko, et al.
Publicado: (2022)

Levosimendan: current data, clinical use and future development
por: Nieminen, M S, et al.
Publicado: (2013)

Inotropes and Inodilators for Acute Heart Failure: Sarcomere Active Drugs in Focus
por: Nagy, László, et al.
Publicado: (2014)

Intermittent levosimendan infusions in advanced heart failure: a real world experience
por: Ortis, Benedetta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jst1dub4228r61e4mrrj5i135q